LONDON, Nov. 11, 2025 /PRNewswire/ — Elliott Investment Management L.P. and Elliott Advisors (UK) Limited ("Elliott"), which advise funds that together have a significant ownership stake in Toyota Industries Corporation ("Toyota Industries" or the "Company"), making Elliott one of the Company’s largest shareholders, today issued the following statement:

Elliott confirms that it has a significant investment in Toyota Industries and that it has been sharing its views with the Company’s management team, Board and other constituents regarding the proposed transaction with Toyota Fudosan. Elliott believes the proposed transaction very significantly undervalues Toyota Industries and reflects a process that has lacked transparency and has fallen short of proper governance practices.

About Elliott

Elliott Investment Management L.P. (together with its affiliates, "Elliott") manages approximately $76.1 billion of assets as of June 30, 2025. Founded in 1977, it is one of the oldest funds under continuous management. The Elliott funds’ investors include pension plans, sovereign wealth funds, endowments, foundations, funds-of-funds, high net worth individuals and families, and employees of the firm. Elliott Advisors (UK) Limited is an affiliate of Elliott Investment Management L.P.

Media Contacts:

LondonStijn van de GrampelElliott Advisors (UK) LimitedT: +44 20 3009 1061svdgrampel@elliottadvisors.co.uk

New YorkStephen SpruiellElliott Investment Management L.P.T: +1 (212) 478-2017sspruiell@elliottmgmt.com

TokyoBrett WallbuttonAshton ConsultingT: +81 (0) 3 5425-7220b.wallbutton@ashton.jp 

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Drake International Mourns the Passing of Founder Bill Pollock

The Winnipeg-born entrepreneur who pioneered an industry, championed opportunity and spent 75…

HanchorBio Accelerates Global Clinical Footprint with Multiple Oral and Poster Presentations in Q1 2026

Sustained execution and high-impact data across HanchorBio’s next-generation immuno-oncology portfolio to be…

CIFM / interzum guangzhou 2026: Visitor Registration Open for the "Smart Revolution"

GUANGZHOU, China, Nov. 26, 2025 /PRNewswire/ — CIFM / interzum guangzhou 2026…